No price history available.
Key financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INRm | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating profit | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | INRm | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS reported | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | INRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | INR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in INR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Vital Chemtech Limited manufactures and supplies phosphorus base chemicals in India and internationally. The company offers a range of phosphorus derivates, including phosphorus trichloride, phosphorus oxychloride, phosphorus pentachloride, phosphorus pentoxide, poly phosphoric acid, ortho phosphoric acid, and phosphorus pentasulfide. It also provides industrial chemicals, such as acetyl chloride, sodium benzoate, and sodium methoxide solution and powder; specialty chemicals and intermediates; organophosphates, including hydroxy ethyledene phosphonic acid, and disodium and tetra sodium salt of HEDP; and polymers and dispersants, which consist of poly acrylic acid-acrylic homo polymer, sodium poly acylates, carboxylate sulphonate co polymer, carboxylate sulphonate non ionic ter polymer, multi functionalter polymer, poly maleic acid, acrylic maleic co polymer, and anti back staining polymer/washing off polymer. In addition, the company offers wellness products comprising soft gel, immune health, heart health, protein support, cognitive health and mental performance, performance and fertility, dietary supplements and weight management, probiotics, blood sugar management, and sports nutrition; and skin, hair, nail, and sugar control products, as well as bones, joints, muscles health, and herbal products. Its products are used in life science, crop care, specialty chemicals, textile auxiliaries, dyes, pigments, and plastic additives applications. Vital Chemtech Limited was founded in 1993 and is based in Ahmedabad, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Vital Chemtech Ltd. (VITAL.NS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Vital Chemtech Limited manufactures and supplies phosphorus base chemicals in India and internationally. The company offers a range of phosphorus derivates, including phosphorus trichloride, phosphorus oxychloride, phosphorus pentachloride, phosphorus pentoxide, poly phosphoric acid, ortho phosphoric acid, and phosphorus pentasulfide. It also provides industrial chemicals, such as acetyl chloride, sodium benzoate, and sodium methoxide solution and powder; specialty chemicals and intermediates; organophosphates, including hydroxy ethyledene phosphonic acid, and disodium and tetra sodium salt of HEDP; and polymers and dispersants, which consist of poly acrylic acid-acrylic homo polymer, sodium poly acylates, carboxylate sulphonate co polymer, carboxylate sulphonate non ionic ter polymer, multi functionalter polymer, poly maleic acid, acrylic maleic co polymer, and anti back staining polymer/washing off polymer. In addition, the company offers wellness products comprising soft gel, immune health, heart health, protein support, cognitive health and mental performance, performance and fertility, dietary supplements and weight management, probiotics, blood sugar management, and sports nutrition; and skin, hair, nail, and sugar control products, as well as bones, joints, muscles health, and herbal products. Its products are used in life science, crop care, specialty chemicals, textile auxiliaries, dyes, pigments, and plastic additives applications. Vital Chemtech Limited was founded in 1993 and is based in Ahmedabad, India.